CN111973501A - Ceramide activation milk and preparation method thereof - Google Patents
Ceramide activation milk and preparation method thereof Download PDFInfo
- Publication number
- CN111973501A CN111973501A CN201911235347.3A CN201911235347A CN111973501A CN 111973501 A CN111973501 A CN 111973501A CN 201911235347 A CN201911235347 A CN 201911235347A CN 111973501 A CN111973501 A CN 111973501A
- Authority
- CN
- China
- Prior art keywords
- component
- parts
- components
- mixture
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 title claims abstract description 79
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 title claims abstract description 49
- 229940106189 ceramide Drugs 0.000 title claims abstract description 49
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 title claims abstract description 49
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 title claims abstract description 49
- 235000013336 milk Nutrition 0.000 title claims abstract description 22
- 210000004080 milk Anatomy 0.000 title claims abstract description 22
- 239000008267 milk Substances 0.000 title claims abstract description 21
- 230000004913 activation Effects 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 153
- 239000000284 extract Substances 0.000 claims abstract description 65
- 241001519524 Kappaphycus alvarezii Species 0.000 claims abstract description 52
- 241001424341 Tara spinosa Species 0.000 claims abstract description 52
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 36
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 36
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 31
- 238000000855 fermentation Methods 0.000 claims abstract description 29
- 230000004151 fermentation Effects 0.000 claims abstract description 29
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 27
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 27
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 27
- 241000199919 Phaeophyceae Species 0.000 claims abstract description 26
- 241000831729 Phyllacantha Species 0.000 claims abstract description 26
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 23
- 239000006166 lysate Substances 0.000 claims abstract description 21
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims abstract description 18
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims abstract description 18
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims abstract description 18
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 79
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 73
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 50
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 40
- 238000000605 extraction Methods 0.000 claims description 35
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 29
- 235000011187 glycerol Nutrition 0.000 claims description 28
- 238000003756 stirring Methods 0.000 claims description 22
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 19
- 229930182478 glucoside Natural products 0.000 claims description 18
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 18
- 238000001816 cooling Methods 0.000 claims description 16
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 14
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 14
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 14
- 229940036350 bisabolol Drugs 0.000 claims description 14
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 14
- 230000001804 emulsifying effect Effects 0.000 claims description 13
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 12
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 12
- 108010087806 Carnosine Proteins 0.000 claims description 12
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 12
- 229940044199 carnosine Drugs 0.000 claims description 12
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 12
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 11
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 11
- 229930003799 tocopherol Natural products 0.000 claims description 11
- 239000011732 tocopherol Substances 0.000 claims description 11
- 241000221095 Simmondsia Species 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 9
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 9
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 claims description 9
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 9
- 241001530056 Athelia rolfsii Species 0.000 claims description 9
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 9
- 244000044822 Simmondsia californica Species 0.000 claims description 9
- 229920006037 cross link polymer Polymers 0.000 claims description 9
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 9
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 9
- 150000008131 glucosides Chemical class 0.000 claims description 9
- -1 glycerol glucoside Chemical class 0.000 claims description 9
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 9
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 9
- 229940049964 oleate Drugs 0.000 claims description 9
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 9
- 229940032094 squalane Drugs 0.000 claims description 9
- 229960001295 tocopherol Drugs 0.000 claims description 9
- 235000010384 tocopherol Nutrition 0.000 claims description 9
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 9
- 241000235347 Schizosaccharomyces pombe Species 0.000 claims description 8
- 230000009089 cytolysis Effects 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 235000019198 oils Nutrition 0.000 claims description 8
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 6
- 241001504226 Hoodia Species 0.000 claims description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 6
- 235000017277 hoodia Nutrition 0.000 claims description 6
- 238000005086 pumping Methods 0.000 claims description 6
- SCVVSSZVLZQUDZ-UHFFFAOYSA-N 3-methyl-2,6-dihydro-1H-pyrimidine-2-carboxylic acid Chemical compound CN1C(NCC=C1)C(=O)O SCVVSSZVLZQUDZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000498 cooling water Substances 0.000 claims description 4
- 238000007599 discharging Methods 0.000 claims description 4
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 241000235346 Schizosaccharomyces Species 0.000 claims description 2
- 241000219304 Portulacaceae Species 0.000 claims 5
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 4
- 230000000694 effects Effects 0.000 abstract description 25
- 230000003750 conditioning effect Effects 0.000 abstract description 6
- 239000000419 plant extract Substances 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 88
- 239000000047 product Substances 0.000 description 44
- 230000006870 function Effects 0.000 description 13
- 230000003020 moisturizing effect Effects 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 10
- 239000003974 emollient agent Substances 0.000 description 10
- 239000003921 oil Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 6
- 239000011731 tocotrienol Substances 0.000 description 6
- 229930003802 tocotrienol Natural products 0.000 description 6
- 235000019148 tocotrienols Nutrition 0.000 description 6
- 229940068778 tocotrienols Drugs 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 229920002305 Schizophyllan Polymers 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 125000002640 tocopherol group Chemical class 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ADOHEWVFRZKRHE-UHFFFAOYSA-N 2-acetyloxyethyl(trimethyl)azanium Chemical compound CC(=O)OCC[N+](C)(C)C.CC(=O)OCC[N+](C)(C)C ADOHEWVFRZKRHE-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 235000008658 Artemisia capillaris Nutrition 0.000 description 1
- 241000092668 Artemisia capillaris Species 0.000 description 1
- 235000003069 Artemisia scoparia Nutrition 0.000 description 1
- 241001249148 Artemisia scoparia Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 241000442274 Heteropappus Species 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 210000003560 epithelium corneal Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000002103 nanocoating Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000010686 shark liver oil Substances 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses ceramide activation milk and a preparation method thereof, wherein the ceramide activation milk comprises the following components in parts by weight: the components of 10: 1.5-2.5 parts of ceramide (3) mixture; and (2) component 12: extracting brown algae (PHYLLACANTHA FIBROSA) to obtain mixture 1.5-2.5; a component 13: extracting Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) to obtain mixture 1.5-2.5; component 14: extracting Caesalpinia spinosa (CAESALPINIA SPINOSA) fruit to obtain mixture 1.5-2.5; the components of 15: a split yeast fermentation lysate mixture 1.5-2.5; the components of 16: octyl methicone 1.5 to 2.5; a component 17: acetyl hexapeptide-8 mixture 1.5-2.5; a component 19: 0.8-1.2 parts of sodium hyaluronate mixture; the components of 22: herba Portulacae (Portulaca OLERACEA) extract mixture 0.4-0.6. The invention adopts pure plant extracts as the conditioner, can deeply nourish the skin, and keeps each medicinal preparation in a reasonable range, thereby not only ensuring effective conditioning, but also not generating stronger side effect.
Description
Technical Field
The invention relates to daily chemical articles, in particular to ceramide activation milk and a preparation method thereof.
Background
The activation lotion is used for supplementing moisture to skin, increasing skin elasticity, improving rough and loose skin, smoothing and moistening skin, and softening and moistening skin, and is generally used after face cleaning.
However, most of the active milks with skin conditioning currently adopt chemicals or even antibiotics. Although this method has a fast and good therapeutic effect, it causes imbalance of skin secretion and causes drug resistance and tolerance, so that its side effects are also great. Especially, the existing activated milk products with different shapes and colors cannot be differentiated by consumers due to limited knowledge. Even if the plant formula is marked for storage, the plant formula also has great side effects due to improper selection and proportion of the components.
Disclosure of Invention
In view of the above-mentioned defects of the prior art, the technical problem to be solved by the present invention is to provide a ceramide-activating milk and a preparation method thereof, wherein a plant formula is adopted, and each component is controlled in an effective range, so that the functions of maintenance and conditioning can be achieved, and major side effects can be prevented from being generated.
In order to realize the purpose, the invention provides ceramide activation milk which comprises the following components in parts by weight:
Component 1: 47-51 parts of water
And (2) component: 5-7 parts of glycerin
And (3) component: butanediol 4-6
And (4) component: 3-5 parts of squalane
And (5) component: jojoba (Simmondsia CHINENSIS) seed oil 3-5
And (4) component 6: butyrospermum PARKII (Butyrumparkii) fruit fat 2-4
And (4) component 7: isopropyl myristate 2-4
And (4) component 8: cetearyl glucoside 2-4
And (3) component 9: decyl Hoodia oleate 2-4
The components of 10: ceramide (3) mixture 1.5-2.5
The components of (11): tocopherol (vitamin E)1.5-2.5
And (2) component 12: brown algae (PHYLLACANTHA FIBROSA) extract mixture 1.5-2.5
A component 13: extracting Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) to obtain mixture 1.5-2.5
Component 14: the extract mixture of Caesalpinia Spinosa (CAESALPINIA SPINOSA) fruit is 1.5-2.5
The components of 15: two split yeast fermentation product lysate mixture 1.5-2.5
The components of 16: octyl methicone 1.5-2.5
A component 17: acetyl hexapeptide-8 mixture 1.5-2.5
The components of 18: carnosine 0.8-1.2
A component 19: 0.8-1.2 parts of sodium hyaluronate mixture
The components are as follows: hydrolyzed SCLEROTIUM rolfsii (scleritium ROLFSSII) gum 0.4-0.6
The components of 21: 0.4-0.6 of p-hydroxyacetophenone mixture
The components of 22: herba Portulacae (Portulaca OLERACEA) extract mixture 0.4-0.6
Component 23: glycerol glucoside 0.4-0.6
And (3) component 24: tetrahydro-methyl-pyrimidine-carboxylic acid 0.2-0.4
Component 25: dipotassium glycyrrhizinate 0.2-0.4
The component (26): acrylic acid (ester) crosslinked polymer 0.2-0.4
The components of 27: bisabolol 0.2-0.4
Component 28: EDTA disodium 0.04-0.06
The component (29): 0.004-0.008 of essence;
the components of 10: the ceramide (3) mixture comprises the following components in parts by weight: 28-32 parts of ceramide (3), 68-72 parts of hydrogenated lecithin;
and (2) component 12: the brown algae (PHYLLACANTHA FIBROSA) extraction mixture comprises the following components in parts by weight: 28-32 parts of brown algae (PHYLLACANTHA FIBROSA) extract, 38-42 parts of glycerol and 26-34 parts of water;
a component 13: the Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture comprises the following components in parts by weight: 18-22 parts of Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract, 28-32 parts of butanediol and 46-54 parts of water;
component 14: the Caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture comprises the following components in parts by weight: 28-32 parts of Caesalpinia Spinosa (CAESALPINIA SPINOSA) fruit extract, 18-22 parts of butanediol and 46-54 parts of water;
the components of 15: the lysis mixture of the secondary fission yeast fermentation product comprises the following components in parts by weight: 38-42 parts of schizosaccharomyces cerevisiae fermentation product lysate, 28-32 parts of butanediol and 26-34 parts of water;
a component 17: the acetyl hexapeptide-8 mixture comprises the following components in parts by weight: acetyl hexapeptide-828-32, water 68-72;
A component 19: the sodium hyaluronate mixture comprises the following components in parts by weight: 9-11 parts of sodium hyaluronate and 89-91 parts of water;
the components of 21: the p-hydroxyacetophenone mixture comprises the following components in parts by weight: 18-22 parts of p-hydroxyacetophenone, 68-72 parts of isoprene glycol and 6-14 parts of 1, 2-hexanediol;
the components of 22: the purslane (Portulaca OLERACEA) extraction mixture comprises the following components in parts by weight: 18-22 parts of purslane (Portulaca OLERACEA) extract, 38-42 parts of butanediol and 36-44 parts of water.
The component 1 is used as a solvent for dissolving and mixing the components;
the component 2 is used as humectant, glycerin, softening, moisturizing, makeup removing solvent and lubricant. Undiluted 100% pure glycerol can never be used directly, which would have adverse effects. Glycerol has a water-absorbing effect, and is often used in moisturizing skin care products to absorb water molecules in the air, so that the stratum corneum of the skin covered by the moisturizing skin care product is kept moist.
Component 3 acts as a humectant, and butylene glycol can increase product smoothness, and is widely used in cosmetics, possibly producing a slight irritating sensation, but there is no evidence of sensitization, and both CIR and FDA have so far evaluated this component as safe. The skin care product is commonly used as a micromolecule moisturizing component, can retain water in the horny layer, has good hygroscopicity, can absorb water which is equivalent to 12.5 percent (relative humidity is 50 percent) and 38.5 percent (relative humidity is 80 percent) of the mass of the skin care product, and also has a certain bacteriostatic action.
The component 4 is taken as an emollient, squalane is extracted from deep sea shark liver or olive oil, is a natural component of skin, has good antioxidant capacity and stimulation immunity, can be rapidly dissolved with moisture and grease in the skin to form a natural skin protection barrier, has excellent stability, can not generate oxidation with air, ultraviolet rays and the like, can effectively protect the skin from being damaged by external substances, has excellent permeability and high-efficiency oxygen carrying performance, can adjust the water-oil balance of the skin, avoids rough and dark skin and recovers the original tender touch of the skin. Is especially suitable for cold seasons, is a skin lubricating oil, and can supplement natural sebum of skin.
The component 5 is used as emollient, and jojoba (SIMMONDSIA CHINENSIS) seed oil is not easy to be oxidized, and has high temperature resistance, high pressure resistance and small viscosity change. It is also superior in touch and extensibility to other vegetable oils, has soft and elastic feeling to the skin, and is easily absorbed by the skin, and is an excellent oil, moisturizer and moisturizer in cosmetics.
Component 6 is used as emollient, and is prepared from fruit fat of Butyrospermum PARKII (Butyrospermum PARKII) by extracting from fruit of Butyrospermum PARKII, contains abundant unsaturated fatty acid, and can enhance skin moisture-keeping ability and moisten dry skin, i.e. cutin-damaged skin. Meanwhile, the fluidity of the product can be adjusted, the viscosity can be improved, and the sensory quality and the use skin feeling of the product can be improved.
Component 7 is used as emollient, isopropyl myristate is used as binder, emollient and keratolytic agent in cosmetics, and the product containing the component is easy to apply and has refreshing texture. The component has small molecule, easy penetration, and good cleaning effect for removing makeup.
The component 8 is used as an emulsifier, and the cetearyl glucoside is used as an emulsifier in cosmetics, so that the moisturizing effect of the product can be enhanced, and the texture is fresh and cool.
Component 9 acts as an emollient, decyl jojoba oleate has strong penetration and dissolution ability, and can be used as a carrier for many ester soluble active ingredients. Can be used alone or in combination with other oils for producing emollient oils. Can be used in cosmetic creams, two emulsion type emulsions.
Component 10 acts as an emollient, and its ceramide (3) is a lipid material, a synthetic ingredient, structurally similar to the materials that make up the stratum corneum of the skin, and can rapidly penetrate into the skin, aid in the renewal of the natural protective layer of the skin, promote the balance of natural hydration, and bind with water in the stratum corneum to form a network that retains water. The skin moisturizing and repairing cream has good effects on skin moisturizing and repairing, is an important skin activating component in the horny layer, and can enhance the skin barrier, rebuild cells and form an effective barrier to prevent water loss and reduce the influence of the external environment. More ceramide is particularly needed in irritated skin and it has been shown that rubbing a product containing a ceramide component reduces redness and swelling and loss of moisture through the skin, acting to enhance the skin barrier and help the damaged skin to relieve dry conditions. The hydrogenated lecithin is a partial hydrolysate of lecithin, and the hydrogenated lecithin improves its hydrophilic ability. Can be absorbed by human skin and hair and promote the penetration of other nutrients, and is often used in conditioning cosmetics together with linolenic acid, hyaluronic acid and vitamins, and lecithin has strong emulsifying effect, can stabilize emulsion, and is suitable for preparing gel products.
Component 11 acts as an emollient, tocopherol (vitamin E) is a treatment for two chemicals: the biological effects of both chemical substances in vivo are approximately the same, but the activities are different, as a general term for tocopherols and tocotrienols. There are four types of both tocopherols and tocotrienols: alpha, beta, gamma, and delta, the difference between which is the number and position of methyl groups on the phenol ring; the difference between tocotrienols is in their unsaturated side chains. Tocotrienols (Tocotrienols) belong to the class of vitamin E. Like vitamin E, tocotrienols are also quite potent antioxidants, and are able to combat lipid peroxidation.
Component 12 is used as skin conditioner, and the extract of brown algae (PHYLLACANTHA FIBROSA) mainly contains alginate jelly, vitamins, amino acids, etc. Is a natural moisturizing and softening agent, can promote cell regeneration, has the function of strengthening skin metabolism, has unique function of removing cutin, can refresh skin, and prevents wrinkles.
Component 13 is used as skin conditioner, and its Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract belongs to red algae. Contains multiple vitamins and colloid. Can moisturize, maintain the elasticity of skin, ensure the smoothness and the elasticity of the skin, moisturize and lock water, and nourish the skin.
Component 14 can be used as skin conditioner, and its Caesalpinia Spinosa (CAESALPINIA SPINOSA) fruit extract has heat and toxic materials clearing away, antibacterial, and anti-inflammatory effects.
Component 15 is used as skin conditioner, and the lysate of yeast fermentation product is obtained by culturing, inactivating and decomposing Bacillus bifidus to obtain metabolite, cytoplasm fragment, cell wall component and polysaccharide complex. However, the Chinese name is the lysate of the yeast fermentation product of the second split, which has no relation with yeast, belongs to the behavior of light by the word "yeast", and the extraction process is similar to the lysate of the yeast fermentation product. Has strong immunosuppressive activity, can promote DNA repair, can effectively protect skin from being damaged by ultraviolet rays, is used for skin care, sun protection and after-sun care products of emulsion, water-based and hydroalcoholic systems, and helps to prevent photoaging of epidermis and dermis. The yeast fermentation product lysate can generate small molecules which comprise vitamin B group, minerals, amino acids and the like and are beneficial to skin care, and the yeast essence is high-quality yeast essence only used for skin care. It has effects in promoting metabolism of stratum corneum, capturing free radicals, inhibiting lipid peroxidation, whitening skin, and resisting aging. The product is rich in nutrients, and has skin nourishing effect.
Component 16 acts as an emollient, octyl methicone, which adds texture to the product, making it fresh and easy to apply.
Component 17 acts as a skin conditioner, with acetyl hexapeptide-8 being a bioactive polypeptide that both reduces existing facial wrinkles and effectively prevents new wrinkles from developing. The release of the nerve conduction element acetylcholine (acetylcholine) is inhibited to reduce the contraction of muscles, thereby achieving the purpose of reducing the generation of dynamic lines and expression lines.
Component 18 acts as a skin conditioner and the fibroblast survival time in dilute aqueous solution of carnosine is significantly prolonged, which indicates that carnosine is not only a nutrient but also can promote the metabolism of cells and delay aging. The medicinal cream can be used as wound healing promoter. Carnosine can capture free oxygen free radicals, particularly effectively prevent oxidation of protein components and has a whitening function; can be used together with urocanic acid for preventing light sensitive dermatitis; carnosine is also readily absorbed by the skin, hair and scalp and contributes to penetration.
The component 19 is used as a skin conditioner, sodium hyaluronate of the skin conditioner is also called as sodium hyaluronate, belongs to a skin conditioner, is an acidic mucopolysaccharide, naturally exists in corneal epithelium, can absorb 1000 times of water by the weight of the acidic mucopolysaccharide, so as to achieve the purposes of keeping the water of the skin, preventing the water from losing through the epidermis and repairing a barrier when the skin is damaged, ensure that the skin does not feel dry and increase the luster after being used, improve the skin nutrition metabolism, make the skin soft and smooth, remove wrinkles, increase the elasticity and prevent aging, and is a good transdermal absorption promoter while keeping moisture. The nutrient can be used together with other nutrient components to achieve the more ideal effect of promoting nutrient absorption.
The component 20 is used as skin conditioner, hydrolyzed SCLEROTIUM rolfsii (scleroglucan) gum is natural polymer of polysaccharide, also called scleroglucan, is stable at various pH values under high temperature, is polysaccharide polymer, has good compatibility with skin, can effectively form film, and has stability.
Component 21 is used as solvent for dissolving organic components, wherein p-hydroxyacetophenone is a natural plant extract, and is naturally present in stems and leaves of Artemisia scoparia of Compositae, and roots of Artemisia capillaris Thunb, Asclepiadaceae, and Heteropappus japonicus Thunb. A multifunctional cosmetic ingredient having antioxidant and soothing effects; the preservative can be used as a substitute of the traditional preservative in cosmetics, has the functions of antisepsis and synergism, can promote the efficacy of various preservatives, and has excellent stability in high and low pH and temperature ranges. Can be used in various formulations, including sunscreen and shampoo. It has good compatibility with various cosmetic components and packaging materials. The isoprene glycol is a deodorization component with remarkable effect. Can enhance the antibacterial performance of alcohols and dihydric alcohols and enhance the traditional antiseptic system. Meanwhile, the skin care product has the effects of moisturizing and mildly moisturizing, and can improve the skin feeling of a cosmetic formula. The 1, 2-hexanediol belongs to polyhydric alcohol, has a bacteriostatic effect, and has a preservative effect only when the addition amount is about 5%.
The component 22 is used as skin conditioner, and herba Portulacae (Portulaca OLERACEA) extract has broad-spectrum antibacterial and antiinflammatory effects, and can be used for preventing and treating dermatoses such as skin eczema, allergic dermatitis, and contact dermatitis; the product has good oxygen free radical scavenging ability, which shows that the product has obvious antioxidation function; has good skin moisture keeping effect.
The component 23 is used as humectant, and glyceryl glucoside is a substance formed by combining glycerol and glucose molecule by glycosidic bond, and has moisturizing and antioxidant effects.
The component 24 is used as a skin conditioner, and the tetrahydro-methyl pyrimidine carboxylic acid is also called Ectoin (Ectoin) and exists in halotolerant bacteria as an osmotic pressure compensation solute, plays a chemical transmitter-like role in cells, has a stable protection effect on the cells in adverse environment, can also stabilize the structure of enzyme protein in organisms, and has the functions of activating skin and resisting aging; can provide good moisturizing and sun-screening functions and has the function of whitening the skin; tetrahydromethylpyrimidine carboxylic acids also protect neutrophils and show anti-inflammatory effects.
Component 25 is used as skin conditioner, and dipotassium glycyrrhizinate is glycyrrhizin (glycyrrhizic acid) component of radix Glycyrrhizae root and stem suitable for allergic skin, and has effects of resisting irritation, controlling oil, reducing red swelling, relieving inflammation, and healing. Can effectively prevent sensitive inflammation phenomenon when skin is stimulated. Has the effects of diminishing inflammation and tranquilizing caused by sunshine, and is often used in antiallergic and repairing cosmetics.
Component 26 acts as a thickener and the cross-linked polymer of acrylic acid (ester) type mainly has the function of adsorbing various organic components, thereby forming a viscous product.
The component 27 is used as a skin conditioner, and the bisabolol is extracted from chrysanthemum plants, has the functions of anti-inflammation and bacteriostasis, has good stability and good compatibility with skin, reduces skin inflammation, relieves skin acne, prevents acne, improves the anti-irritation capacity of the skin, repairs the skin with inflammation injury, and improves the SPF value in a sun-screening product. The bisabolol has obvious anti-inflammatory and antispasmodic effects, and on the function, the natural bisabolol has twice of the effects of a synthetic product, has the functions of relieving pain, alleviating irritation and resisting allergy, and has skin care effect on allergic skin or children skin. Bisabolol has sedative and antiperspirancy effects, and is commonly used in sunscreen products and ointments for treating sunburn and burn; has broad-spectrum antibacterial property, and can reduce dental plaque and gingival allergy and prevent and treat halitosis when being used in toothpaste; the bisabolol has high permeability on the skin cortex, and the action of the bisabolol is dozens of times of that of a common penetrant; can be used as main agent or adjuvant for preventing and treating skin diseases such as acne, and also has skin conditioning effect.
Component 28 is used as chelating agent, disodium EDTA has stabilizing effect in cosmetic, and mineral chelating agent has synergistic antiseptic effect. And has a certain synergistic effect on an anticorrosion system and an antioxidant system.
Component 29 acts as a fragrance, which is used to provide a fragrance.
The INCI names for each component are as follows:
the preparation method of the ceramide activation milk comprises the following steps:
s1, sequentially putting the component 1, the component 2, the component 3, the component 21 and the component 28 into a water phase pot of an emulsifying pot, stirring, heating to 80-90 ℃, and keeping for more than 20 minutes to obtain a first intermediate;
s2, sequentially putting the component 4, the component 5, the component 6, the component 7, the component 8, the component 9 and the component 11 into an oil phase pot of an emulsifying pot, stirring at the speed of 50 revolutions per minute, heating to 75-80 ℃, and keeping for more than 20 minutes to obtain a second intermediate;
s3, vacuumizing the heated first intermediate into a main emulsifying pot, homogenizing for 5 minutes or more, then pumping into a second intermediate, homogenizing for 5 minutes or more, and preserving heat for 20 minutes or more to obtain a third intermediate;
s4, opening cooling water, cooling the third intermediate to 65-70 ℃, adding the component 19, the component 25, the component 26 and the component 27, homogenizing for 5 minutes or more, and uniformly dissolving to obtain a fourth intermediate;
S4, cooling the fourth intermediate to 55-60 ℃, sequentially adding the component 10 and the component 16, and stirring for dissolving to obtain a fifth intermediate;
s5, cooling the fifth intermediate to 40-45 ℃, sequentially adding the component 12, the component 13, the component 14, the component 15, the component 16, the component 17, the component 18, the component 20, the component 22, the component 23, the component 24 and the component 29, and stirring to dissolve completely to obtain a finished product;
s6, cooling the finished product to 35-40 ℃, stopping stirring, and discharging. The applicant has designed the above preparation method because the components can withstand different temperatures and need to be dissolved and mixed one by one according to the principle of similar solubility. The method can ensure the activity of each component on the premise of ensuring that each component is fully dissolved and mixed, thereby ensuring the efficacy of a final finished product.
The invention has the beneficial effects that: the invention adopts pure plant extracts as the conditioner, can deeply nourish the skin, and keeps each medicinal preparation in a reasonable range, thereby not only ensuring effective conditioning, but also not generating stronger side effect.
The skin care product can keep moisture and moisten, has fresh skin feel, is not sticky, has good moistening degree and long moisture-keeping time, well repairs damaged skin, and in addition, the ceramide is wrapped by the nano coating, so that the skin absorption effect can be better improved, and the ceramide can more effectively permeate into the deep layer of the skin.
Detailed Description
The invention is further illustrated by the following examples:
example one
A ceramide activation milk comprises the following components in parts by weight:
component 1: water 48.045
And (2) component: glycerol 6
And (3) component: butanediol 5
And (4) component: squalane 4
And (5) component: jojoba (Simmondsia CHINENSIS) seed oil 4
And (4) component 6: butyrospermum PARKII (Butyrum PARKII) fruit fat 3
And (4) component 7: isopropyl myristate 3
And (4) component 8: cetearyl glucoside 3
And (3) component 9: decyl Hoodia oleate 3
The components of 10: ceramide (3) mixture 2
The components of (11): tocopherol (vitamin E)2
And (2) component 12: brown algae (PHYLLACANTHA FIBROSA) extraction mixture 2
A component 13: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture 2
Component 14: caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture 2
The components of 15: two split yeast fermentation product lysate mixture 2
The components of 16: octyl methicone 2
A component 17: acetyl hexapeptide-8 mixture 2
The components of 18: carnosine 1
A component 19: sodium hyaluronate mixture 1
The components are as follows: hydrolyzed SCLEROTIUM rolfsii (scleritium ROLFSSII) gum 0.5
The components of 21: p-hydroxyacetophenone mixture 0.5
The components of 22: herba Portulacae (Portulaca OLERACEA) extract mixture 0.5
Component 23: glycerol glucoside 0.5
And (3) component 24: tetrahydrophylpyrimidine carboxylic acid 0.3
Component 25: dipotassium glycyrrhizinate 0.2
The component (26): acrylic acid (ester) crosslinked Polymer 0.2
The components of 27: bisabolol 0.2
Component 28: EDTA disodium 0.05
The component (29): 0.005 of essence;
the components of 10: the ceramide (3) mixture comprises the following components in parts by weight: ceramide (3)30, hydrogenated lecithin 70;
and (2) component 12: the brown algae (PHYLLACANTHA FIBROSA) extraction mixture comprises the following components in parts by weight: 30 parts of brown algae (PHYLLACANTHA FIBROSA) extract, 40 parts of glycerol and 30 parts of water;
a component 13: the Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture comprises the following components in parts by weight: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract 20, butanediol 30, and water 20;
component 14: the Caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture comprises the following components in parts by weight: 30 parts of Caesalpinia Spinosa (CAESALPINIA SPINOSA) fruit extract, 20 parts of butanediol and 50 parts of water;
the components of 15: the lysis mixture of the secondary fission yeast fermentation product comprises the following components in parts by weight: split yeast fermentation product lysate 40, butanediol 30, water 30;
a component 17: the acetyl hexapeptide-8 mixture comprises the following components in parts by weight: acetyl hexapeptide-830, water 70;
A component 19: the sodium hyaluronate mixture comprises the following components in parts by weight: 10 parts of sodium hyaluronate and 90 parts of water;
the components of 21: the p-hydroxyacetophenone mixture comprises the following components in parts by weight: p-hydroxyacetophenone 20, isoprene glycol 70, 1, 2-hexanediol 10;
the components of 22: the purslane (Portulaca OLERACEA) extraction mixture comprises the following components in parts by weight: herba Portulacae (Portulaca OLERACEA) extract 20, butanediol 40, and water 40.
Example two
A ceramide activation milk comprises the following components in parts by weight:
component 1: water 49
And (2) component: glycerol 5.5
And (3) component: butanediol 4.5
And (4) component: squalane 3.5
And (5) component: jojoba (Simmondsia CHINENSIS) seed oil 3.5
And (4) component 6: butyrospermum PARKII (Butyrum PARKII) fruit fat 2.5
And (4) component 7: isopropyl myristate 2.5
And (4) component 8: cetearyl glucoside 2.5
And (3) component 9: decyl Hoodiol oleate 2.5
The components of 10: ceramide (3) mixture 2.2
The components of (11): tocopherol (vitamin E)2.2
And (2) component 12: brown algae (PHYLLACANTHA FIBROSA) extraction mixture 2.2
A component 13: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture 2.2
Component 14: caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extract mixture 2.2
The components of 15: two split yeast fermentation product lysate mixture 2.2
The components of 16: octyl methicone 2.2
A component 17: acetyl hexapeptide-8 mixture 2.2
The components of 18: carnosine 0.9
A component 19: sodium hyaluronate mixture 0.9
The components are as follows: hydrolyzed SCLEROTIUM rolfsii (scleritium ROLFSSII) gum 0.45
The components of 21: p-hydroxyacetophenone mixture 0.45
The components of 22: herba Portulacae (Portulaca OLERACEA) extract mixture 0.45
Component 23: glycerol glucoside 0.45
And (3) component 24: tetrahydrophylpyrimidine carboxylic acid 0.25
Component 25: dipotassium glycyrrhizinate 0.25
The component (26): acrylic acid (ester) crosslinked Polymer 0.25
The components of 27: bisabolol 0.25
Component 28: disodium EDTA 0.055
The component (29): 0.007 parts of essence;
the components of 10: the ceramide (3) mixture comprises the following components in parts by weight: ceramide (3)29, hydrogenated lecithin 71;
and (2) component 12: the brown algae (PHYLLACANTHA FIBROSA) extraction mixture comprises the following components in parts by weight: brown algae (PHYLLACANTHA FIBROSA) extract 29, glycerol 39, water 32;
a component 13: the Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture comprises the following components in parts by weight: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract 19, butanediol 29, and water 52;
Component 14: the Caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture comprises the following components in parts by weight: caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extract 29, butanediol 19 and water 52;
the components of 15: the lysis mixture of the secondary fission yeast fermentation product comprises the following components in parts by weight: split yeast fermentation product lysate 39, butanediol 29, water 32;
a component 17: the acetyl hexapeptide-8 mixture comprises the following components in parts by weight: acetyl hexapeptide-829, water 71;
a component 19: the sodium hyaluronate mixture comprises the following components in parts by weight: sodium hyaluronate 9, water 91;
the components of 21: the p-hydroxyacetophenone mixture comprises the following components in parts by weight: p-hydroxyacetophenone 19, isoprene glycol 69, 1, 2-hexanediol 12;
the components of 22: the purslane (Portulaca OLERACEA) extraction mixture comprises the following components in parts by weight: herba Portulacae (Portulaca OLERACEA) extract 19, butanediol 39, and water 42.
EXAMPLE III
A ceramide activation milk comprises the following components in parts by weight:
component 1: 50.5 parts of water
And (2) component: glycerol 6.4
And (3) component: butanediol 5.6
And (4) component: squalane 6
And (5) component: jojoba (Simmondsia CHINENSIS) seed oil 4.6
And (4) component 6: butyrospermum PARKII (Butyrum PARKII) fruit fat 3.6
And (4) component 7: isopropyl myristate 3.6
And (4) component 8: cetearyl glucoside 3.6
And (3) component 9: decyl Hoodia oleate 3.6
The components of 10: ceramide (3) mixture 18
The components of (11): tocopherol (vitamin E)1.8
And (2) component 12: brown algae (PHYLLACANTHA FIBROSA) extraction mixture 1.8
A component 13: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture 1.8
Component 14: caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture 1.8
The components of 15: two split yeast fermentation product lysate mixture 1.8
The components of 16: octyl methicone 1.8
A component 17: acetyl hexapeptide-8 mixture 1.8
The components of 18: carnosine 1.1
A component 19: sodium hyaluronate mixture 1.1
The components are as follows: hydrolyzed SCLEROTIUM rolfsii (scleritium ROLFSSII) gum 0.56
The components of 21: 0.4-0.6 of p-hydroxyacetophenone mixture
The components of 22: herba Portulacae (Portulaca OLERACEA) extract mixture 0.56
Component 23: glycerol glucoside 0.56
And (3) component 24: tetrahydrophylpyrimidine carboxylic acid 0.36
Component 25: dipotassium glycyrrhizinate 0.36
The component (26): acrylic acid (ester) crosslinked Polymer 0.36
The components of 27: bisabolol 0.36
Component 28: EDTA disodium 0.056
The component (29): 0.0056 of essence;
the components of 10: the ceramide (3) mixture comprises the following components in parts by weight: ceramide (3)31, hydrogenated lecithin 69;
and (2) component 12: the brown algae (PHYLLACANTHA FIBROSA) extraction mixture comprises the following components in parts by weight: brown algae (PHYLLACANTHA FIBROSA) extract 31, glycerol 41 and water 28;
a component 13: the Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture comprises the following components in parts by weight: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract 21, butanediol 31, and water 48;
component 14: the Caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture comprises the following components in parts by weight: 31 of Caesalpinia Spinosa (CAESALPINIA SPINOSA) fruit extract, 21 of butanediol and 48 of water;
the components of 15: the lysis mixture of the secondary fission yeast fermentation product comprises the following components in parts by weight: a split yeast fermentation product lysate 41, butanediol 31, water 28;
a component 17: the acetyl hexapeptide-8 mixture comprises the following components in parts by weight: acetyl hexapeptide-831, water 69;
a component 19: the sodium hyaluronate mixture comprises the following components in parts by weight: sodium hyaluronate 11, water 89;
The components of 21: the p-hydroxyacetophenone mixture comprises the following components in parts by weight: p-hydroxyacetophenone 21, isoprene glycol 71, 1, 2-hexanediol 8;
the components of 22: the purslane (Portulaca OLERACEA) extraction mixture comprises the following components in parts by weight: herba Portulacae (Portulaca OLERACEA) extract 21, butanediol 41, and water 38.
Example four
A preparation method of ceramide activation milk comprises the following steps:
s1, sequentially putting the component 1, the component 2, the component 3, the component 21 and the component 28 into a water phase pot of an emulsifying pot, stirring at the speed of 50 revolutions per minute, heating to 90 ℃, and keeping for more than 20 minutes to obtain a first intermediate;
s2, sequentially putting the component 4, the component 5, the component 6, the component 7, the component 8, the component 9 and the component 11 into an oil phase pot of an emulsifying pot, stirring at the speed of 50 revolutions per minute, heating to 80 ℃, and keeping for more than 20 minutes to obtain a second intermediate;
s3, vacuumizing the heated first intermediate, pumping into a main emulsifying pot, homogenizing at 3000 r/min, pumping into a second intermediate, homogenizing for 5 min, stirring at 40 r/min, and keeping the temperature for 20 min or more to obtain a third intermediate;
S4, opening cooling water, cooling the third intermediate to 70 ℃, adding the component 19, the component 25, the component 26 and the component 27, homogenizing for 5 minutes at 3000 r/min, and uniformly dissolving to obtain a fourth intermediate;
s4, cooling the fourth intermediate to 60 ℃, sequentially adding the component 10 and the component 16, and stirring for dissolving to obtain a fifth intermediate;
s5, cooling the fifth intermediate to 45 ℃, sequentially adding the component 12, the component 13, the component 14, the component 15, the component 16, the component 17, the component 18, the component 20, the component 22, the component 23, the component 24 and the component 29, and stirring and dissolving completely to obtain a finished product;
and S6, cooling the finished product to 40 ℃, stopping stirring, and discharging.
The invention is not described in detail, but is well known to those skilled in the art.
The foregoing detailed description of the preferred embodiments of the invention has been presented. It should be understood that numerous modifications and variations could be devised by those skilled in the art in light of the present teachings without departing from the inventive concepts. Therefore, the technical solutions available to those skilled in the art through logic analysis, reasoning and limited experiments based on the prior art according to the concept of the present invention should be within the scope of protection defined by the claims.
Claims (9)
1. The ceramide-activated milk is characterized by comprising the following components in parts by weight:
the components of 10: ceramide (3) mixture 1.5-2.5
And (2) component 12: brown algae (PHYLLACANTHA FIBROSA) extract mixture 1.5-2.5
A component 13: extracting Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) to obtain mixture 1.5-2.5
Component 14: the extract mixture of Caesalpinia Spinosa (CAESALPINIA SPINOSA) fruit is 1.5-2.5
The components of 15: two split yeast fermentation product lysate mixture 1.5-2.5
The components of 16: octyl methicone 1.5-2.5
A component 17: acetyl hexapeptide-8 mixture 1.5-2.5
A component 19: 0.8-1.2 parts of sodium hyaluronate mixture
The components of 22: herba Portulacae (Portulaca OLERACEA) extract mixture 0.4-0.6.
2. The ceramide-activated milk as claimed in claim 2, further comprising the following components in parts by weight:
component 1: 47-51 parts of water
And (2) component: 5-7 parts of glycerin
And (3) component: butanediol 4-6
And (4) component: 3-5 parts of squalane
And (5) component: jojoba (Simmondsia CHINENSIS) seed oil 3-5
And (4) component 6: butyrospermum PARKII (Butyrumparkii) fruit fat 2-4
And (4) component 7: isopropyl myristate 2-4
And (4) component 8: cetearyl glucoside 2-4
And (3) component 9: decyl Hoodia oleate 2-4
The components of (11): tocopherol (vitamin E)1.5-2.5
The components of 18: carnosine 0.8-1.2
The components are as follows: hydrolyzed SCLEROTIUM rolfsii (scleritium ROLFSSII) gum 0.4-0.6
The components of 21: 0.4-0.6 of p-hydroxyacetophenone mixture
Component 23: glycerol glucoside 0.4-0.6
And (3) component 24: tetrahydro methyl pyrimidine carboxylic acid 0.2-0.4.
3. The ceramide-activated milk as claimed in claim 2, further comprising the following components in parts by weight:
component 25: dipotassium glycyrrhizinate 0.2-0.4
The component (26): acrylic acid (ester) crosslinked polymer 0.2-0.4
The components of 27: bisabolol 0.2-0.4
Component 28: EDTA disodium 0.04-0.06
The component (29): 0.004-0.008 of essence.
4. A ceramide-activated milk according to claim 3, characterized by the component 10: the ceramide (3) mixture comprises the following components in parts by weight: 28-32 parts of ceramide (3), 68-72 parts of hydrogenated lecithin;
and (2) component 12: the brown algae (PHYLLACANTHA FIBROSA) extraction mixture comprises the following components in parts by weight: 28-32 parts of brown algae (PHYLLACANTHA FIBROSA) extract, 38-42 parts of glycerol and 26-34 parts of water;
a component 13: the Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture comprises the following components in parts by weight: 18-22 parts of Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract, 28-32 parts of butanediol and 46-54 parts of water;
Component 14: the Caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture comprises the following components in parts by weight: 28-32 parts of Caesalpinia Spinosa (CAESALPINIA SPINOSA) fruit extract, 18-22 parts of butanediol and 46-54 parts of water;
the components of 15: the lysis mixture of the secondary fission yeast fermentation product comprises the following components in parts by weight: 38-42 parts of schizosaccharomyces cerevisiae fermentation product lysate, 28-32 parts of butanediol and 26-34 parts of water;
a component 17: the acetyl hexapeptide-8 mixture comprises the following components in parts by weight: acetyl hexapeptide-828-32, water 68-72;
a component 19: the sodium hyaluronate mixture comprises the following components in parts by weight: 9-11 parts of sodium hyaluronate and 89-91 parts of water;
the components of 21: the p-hydroxyacetophenone mixture comprises the following components in parts by weight: 18-22 parts of p-hydroxyacetophenone, 68-72 parts of isoprene glycol and 6-14 parts of 1, 2-hexanediol;
the components of 22: the purslane (Portulaca OLERACEA) extraction mixture comprises the following components in parts by weight: 18-22 parts of purslane (Portulaca OLERACEA) extract, 38-42 parts of butanediol and 36-44 parts of water.
5. The ceramide-activated milk as claimed in claim 4, which is prepared from the following components in parts by weight:
component 1: water 49
And (2) component: glycerol 5.5
And (3) component: butanediol 4.5
And (4) component: squalane 3.5
And (5) component: jojoba (Simmondsia CHINENSIS) seed oil 3.5
And (4) component 6: butyrospermum PARKII (Butyrum PARKII) fruit fat 2.5
And (4) component 7: isopropyl myristate 2.5
And (4) component 8: cetearyl glucoside 2.5
And (3) component 9: decyl Hoodiol oleate 2.5
The components of 10: ceramide (3) mixture 2.2
The components of (11): tocopherol (vitamin E)2.2
And (2) component 12: brown algae (PHYLLACANTHA FIBROSA) extraction mixture 2.2
A component 13: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture 2.2
Component 14: caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extract mixture 2.2
The components of 15: two split yeast fermentation product lysate mixture 2.2
The components of 16: octyl methicone 2.2
A component 17: acetyl hexapeptide-8 mixture 2.2
The components of 18: carnosine 0.9
A component 19: sodium hyaluronate mixture 0.9
The components are as follows: hydrolyzed SCLEROTIUM rolfsii (scleritium ROLFSSII) gum 0.45
The components of 21: p-hydroxyacetophenone mixture 0.45
The components of 22: herba Portulacae (Portulaca OLERACEA) extract mixture 0.45
Component 23: glycerol glucoside 0.45
And (3) component 24: tetrahydrophylpyrimidine carboxylic acid 0.25
Component 25: dipotassium glycyrrhizinate 0.25
The component (26): acrylic acid (ester) crosslinked Polymer 0.25
The components of 27: bisabolol 0.25
Component 28: disodium EDTA 0.055
The component (29): 0.007 parts of essence;
the components of 10: the ceramide (3) mixture comprises the following components in parts by weight: ceramide (3)29, hydrogenated lecithin 71;
and (2) component 12: the brown algae (PHYLLACANTHA FIBROSA) extraction mixture comprises the following components in parts by weight: brown algae (PHYLLACANTHA FIBROSA) extract 29, glycerol 39, water 32;
a component 13: the Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture comprises the following components in parts by weight: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract 19, butanediol 29, and water 52;
component 14: the Caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture comprises the following components in parts by weight: caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extract 29, butanediol 19 and water 52;
the components of 15: the lysis mixture of the secondary fission yeast fermentation product comprises the following components in parts by weight: split yeast fermentation product lysate 39, butanediol 29, water 32;
a component 17: the acetyl hexapeptide-8 mixture comprises the following components in parts by weight: acetyl hexapeptide-829, water 71;
a component 19: the sodium hyaluronate mixture comprises the following components in parts by weight: sodium hyaluronate 9, water 91;
The components of 21: the p-hydroxyacetophenone mixture comprises the following components in parts by weight: p-hydroxyacetophenone 19, isoprene glycol 69, 1, 2-hexanediol 12;
the components of 22: the purslane (Portulaca OLERACEA) extraction mixture comprises the following components in parts by weight: herba Portulacae (Portulaca OLERACEA) extract 19, butanediol 39, and water 42.
6. The ceramide-activated milk as claimed in claim 4, which is prepared from the following components in parts by weight:
component 1: 50.5 parts of water
And (2) component: glycerol 6.4
And (3) component: butanediol 5.6
And (4) component: squalane 6
And (5) component: jojoba (Simmondsia CHINENSIS) seed oil 4.6
And (4) component 6: butyrospermum PARKII (Butyrum PARKII) fruit fat 3.6
And (4) component 7: isopropyl myristate 3.6
And (4) component 8: cetearyl glucoside 3.6
And (3) component 9: decyl Hoodia oleate 3.6
The components of 10: ceramide (3) mixture 18
The components of (11): tocopherol (vitamin E)1.8
And (2) component 12: brown algae (PHYLLACANTHA FIBROSA) extraction mixture 1.8
A component 13: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture 1.8
Component 14: caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture 1.8
The components of 15: two split yeast fermentation product lysate mixture 1.8
The components of 16: octyl methicone 1.8
A component 17: acetyl hexapeptide-8 mixture 1.8
The components of 18: carnosine 1.1
A component 19: sodium hyaluronate mixture 1.1
The components are as follows: hydrolyzed SCLEROTIUM rolfsii (scleritium ROLFSSII) gum 0.56
The components of 21: 0.4-0.6 of p-hydroxyacetophenone mixture
The components of 22: herba Portulacae (Portulaca OLERACEA) extract mixture 0.56
Component 23: glycerol glucoside 0.56
And (3) component 24: tetrahydrophylpyrimidine carboxylic acid 0.36
Component 25: dipotassium glycyrrhizinate 0.36
The component (26): acrylic acid (ester) crosslinked Polymer 0.36
The components of 27: bisabolol 0.36
Component 28: EDTA disodium 0.056
The component (29): 0.0056 of essence;
the components of 10: the ceramide (3) mixture comprises the following components in parts by weight: ceramide (3)31, hydrogenated lecithin 69;
and (2) component 12: the brown algae (PHYLLACANTHA FIBROSA) extraction mixture comprises the following components in parts by weight: brown algae (PHYLLACANTHA FIBROSA) extract 31, glycerol 41 and water 28;
a component 13: the Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture comprises the following components in parts by weight: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract 21, butanediol 31, and water 48;
component 14: the Caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture comprises the following components in parts by weight: 31 of Caesalpinia Spinosa (CAESALPINIA SPINOSA) fruit extract, 21 of butanediol and 48 of water;
The components of 15: the lysis mixture of the secondary fission yeast fermentation product comprises the following components in parts by weight: a split yeast fermentation product lysate 41, butanediol 31, water 28;
a component 17: the acetyl hexapeptide-8 mixture comprises the following components in parts by weight: acetyl hexapeptide-831, water 69;
a component 19: the sodium hyaluronate mixture comprises the following components in parts by weight: sodium hyaluronate 11, water 89;
the components of 21: the p-hydroxyacetophenone mixture comprises the following components in parts by weight: p-hydroxyacetophenone 21, isoprene glycol 71, 1, 2-hexanediol 8;
the components of 22: the purslane (Portulaca OLERACEA) extraction mixture comprises the following components in parts by weight: herba Portulacae (Portulaca OLERACEA) extract 21, butanediol 41, and water 38.
7. The ceramide-activated milk as claimed in claim 4, which is prepared from the following components in parts by weight:
component 1: water 48.045
And (2) component: glycerol 6
And (3) component: butanediol 5
And (4) component: squalane 4
And (5) component: jojoba (Simmondsia CHINENSIS) seed oil 4
And (4) component 6: butyrospermum PARKII (Butyrum PARKII) fruit fat 3
And (4) component 7: isopropyl myristate 3
And (4) component 8: cetearyl glucoside 3
And (3) component 9: decyl Hoodia oleate 3
The components of 10: ceramide (3) mixture 2
The components of (11): tocopherol (vitamin E)2
And (2) component 12: brown algae (PHYLLACANTHA FIBROSA) extraction mixture 2
A component 13: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture 2
Component 14: caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture 2
The components of 15: two split yeast fermentation product lysate mixture 2
The components of 16: octyl methicone 2
A component 17: acetyl hexapeptide-8 mixture 2
The components of 18: carnosine 1
A component 19: sodium hyaluronate mixture 1
The components are as follows: hydrolyzed SCLEROTIUM rolfsii (scleritium ROLFSSII) gum 0.5
The components of 21: p-hydroxyacetophenone mixture 0.5
The components of 22: herba Portulacae (Portulaca OLERACEA) extract mixture 0.5
Component 23: glycerol glucoside 0.5
And (3) component 24: tetrahydrophylpyrimidine carboxylic acid 0.3
Component 25: dipotassium glycyrrhizinate 0.2
The component (26): acrylic acid (ester) crosslinked Polymer 0.2
The components of 27: bisabolol 0.2
Component 28: EDTA disodium 0.05
The component (29): 0.005 of essence;
the components of 10: the ceramide (3) mixture comprises the following components in parts by weight: ceramide (3)30, hydrogenated lecithin 70;
and (2) component 12: the brown algae (PHYLLACANTHA FIBROSA) extraction mixture comprises the following components in parts by weight: 30 parts of brown algae (PHYLLACANTHA FIBROSA) extract, 40 parts of glycerol and 30 parts of water;
A component 13: the Kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract mixture comprises the following components in parts by weight: kappaphycus ALVAREZII (Kappaphycus ALVAREZII) extract 20, butanediol 30, and water 20;
component 14: the Caesalpinia spinosa (CAESALPINIA SPINOSA) fruit extraction mixture comprises the following components in parts by weight: 30 parts of Caesalpinia Spinosa (CAESALPINIA SPINOSA) fruit extract, 20 parts of butanediol and 50 parts of water;
the components of 15: the lysis mixture of the secondary fission yeast fermentation product comprises the following components in parts by weight: split yeast fermentation product lysate 40, butanediol 30, water 30;
a component 17: the acetyl hexapeptide-8 mixture comprises the following components in parts by weight: acetyl hexapeptide-830, water 70;
a component 19: the sodium hyaluronate mixture comprises the following components in parts by weight: 10 parts of sodium hyaluronate and 90 parts of water;
the components of 21: the p-hydroxyacetophenone mixture comprises the following components in parts by weight: p-hydroxyacetophenone 20, isoprene glycol 70, 1, 2-hexanediol 10;
the components of 22: the purslane (Portulaca OLERACEA) extraction mixture comprises the following components in parts by weight: herba Portulacae (Portulaca OLERACEA) extract 20, butanediol 40, and water 40.
8. A preparation method of ceramide activation milk is characterized by comprising the following steps:
s1, sequentially putting the component 1, the component 2, the component 3, the component 21 and the component 28 into a water phase pot of an emulsifying pot, stirring, heating to 80-90 ℃, and keeping for more than 20 minutes to obtain a first intermediate;
s2, sequentially putting the component 4, the component 5, the component 6, the component 7, the component 8, the component 9 and the component 11 into an oil phase pot of an emulsifying pot, stirring at the speed of 50 revolutions per minute, heating to 75-80 ℃, and keeping for more than 20 minutes to obtain a second intermediate;
s3, vacuumizing the heated first intermediate into a main emulsifying pot, homogenizing for 5 minutes or more, then pumping into a second intermediate, homogenizing for 5 minutes or more, and preserving heat for 20 minutes or more to obtain a third intermediate;
s4, opening cooling water, cooling the third intermediate to 65-70 ℃, adding the component 19, the component 25, the component 26 and the component 27, homogenizing for 5 minutes or more, and uniformly dissolving to obtain a fourth intermediate;
s4, cooling the fourth intermediate to 55-60 ℃, sequentially adding the component 10 and the component 16, and stirring for dissolving to obtain a fifth intermediate;
s5, cooling the fifth intermediate to 40-45 ℃, sequentially adding the component 12, the component 13, the component 14, the component 15, the component 16, the component 17, the component 18, the component 20, the component 22, the component 23, the component 24 and the component 29, and stirring to dissolve completely to obtain a finished product;
S6, cooling the finished product to 35-40 ℃, stopping stirring, and discharging.
9. The method of claim 8, comprising the steps of:
s1, sequentially putting the component 1, the component 2, the component 3, the component 21 and the component 28 into a water phase pot of an emulsifying pot, stirring at the speed of 50 revolutions per minute, heating to 90 ℃, and keeping for more than 20 minutes to obtain a first intermediate;
s2, sequentially putting the component 4, the component 5, the component 6, the component 7, the component 8, the component 9 and the component 11 into an oil phase pot of an emulsifying pot, stirring at the speed of 50 revolutions per minute, heating to 80 ℃, and keeping for more than 20 minutes to obtain a second intermediate;
s3, vacuumizing the heated first intermediate, pumping into a main emulsifying pot, homogenizing at 3000 r/min, pumping into a second intermediate, homogenizing for 5 min, stirring at 40 r/min, and keeping the temperature for 20 min or more to obtain a third intermediate;
s4, opening cooling water, cooling the third intermediate to 70 ℃, adding the component 19, the component 25, the component 26 and the component 27, homogenizing for 5 minutes at 3000 r/min, and uniformly dissolving to obtain a fourth intermediate;
s4, cooling the fourth intermediate to 60 ℃, sequentially adding the component 10 and the component 16, and stirring for dissolving to obtain a fifth intermediate;
S5, cooling the fifth intermediate to 45 ℃, sequentially adding the component 12, the component 13, the component 14, the component 15, the component 16, the component 17, the component 18, the component 20, the component 22, the component 23, the component 24 and the component 29, and stirring and dissolving completely to obtain a finished product;
and S6, cooling the finished product to 40 ℃, stopping stirring, and discharging.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911235347.3A CN111973501A (en) | 2019-12-05 | 2019-12-05 | Ceramide activation milk and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911235347.3A CN111973501A (en) | 2019-12-05 | 2019-12-05 | Ceramide activation milk and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111973501A true CN111973501A (en) | 2020-11-24 |
Family
ID=73441644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911235347.3A Withdrawn CN111973501A (en) | 2019-12-05 | 2019-12-05 | Ceramide activation milk and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111973501A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113230194A (en) * | 2021-04-16 | 2021-08-10 | 敏云(佛山)生物科技有限公司 | Facial essence and beautifying method |
| CN113318056A (en) * | 2021-05-28 | 2021-08-31 | 广州伊尔美生物科技有限公司 | New-born beautifying, firming and wrinkle-removing composition, preparation method thereof and firming and wrinkle-removing cream |
| CN117860631A (en) * | 2024-01-11 | 2024-04-12 | 广东领康日用品有限公司 | Skin care composition with effect of effectively repairing skin barrier, and preparation process and application thereof |
-
2019
- 2019-12-05 CN CN201911235347.3A patent/CN111973501A/en not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| 澳大利亚沃特利制药有限公司: "CEMOY肌底修护精华乳", 《进口普通化妆品备案信息》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113230194A (en) * | 2021-04-16 | 2021-08-10 | 敏云(佛山)生物科技有限公司 | Facial essence and beautifying method |
| CN113318056A (en) * | 2021-05-28 | 2021-08-31 | 广州伊尔美生物科技有限公司 | New-born beautifying, firming and wrinkle-removing composition, preparation method thereof and firming and wrinkle-removing cream |
| CN117860631A (en) * | 2024-01-11 | 2024-04-12 | 广东领康日用品有限公司 | Skin care composition with effect of effectively repairing skin barrier, and preparation process and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106580798B (en) | Full-effect eye cream and preparation method thereof | |
| CN102342993B (en) | Anti-sensitization and restoration external preparation for skin | |
| CN107334726B (en) | Acne-removing composition and preparation method and application thereof | |
| KR102257342B1 (en) | Composition for antimicrobial and anti-inflammatory activities and manufacturing method thereof | |
| CN110638707A (en) | Eye care cream and preparation method thereof | |
| KR101985354B1 (en) | A composition comprising a herbal fermentation extract having preventing and improving acne lesion | |
| GB2451224A (en) | Cosmetic composition comprising an exfoliant, astringent, antioxidant and moisturiser | |
| CN111973486A (en) | Ceramide moisturizing and moisture-keeping cream and preparation method thereof | |
| CN113018238A (en) | Anti-bacterial, anti-inflammatory, refreshing and skin-benefiting acne-removing gel and preparation method thereof | |
| CN111973501A (en) | Ceramide activation milk and preparation method thereof | |
| CN111973481A (en) | Blue ketone peptide repair essence and preparation method thereof | |
| KR101749690B1 (en) | Cosmetic composition for sebum control and pore minimizing containing Wrinkled Giant Hyssop. | |
| KR20090041886A (en) | Vegetable triple moisturizing component and skin care composition comprising the same | |
| KR20080026800A (en) | Cosmetic composition | |
| KR102220534B1 (en) | Soothing cream and manufacturing method for the same | |
| CN114053186A (en) | Long-acting rose essence lotion capable of moisturizing and whitening skin and preparation method thereof | |
| CN113679640A (en) | Natural nourishing skin-cleaning skin-care acne-removing facial cleansing gel and preparation method thereof | |
| CN112057386A (en) | Refreshing, moisturizing, whitening and repairing sun block and preparation method thereof | |
| CN111973487A (en) | Ceramide moisturizing essence and preparation method thereof | |
| CN111973523A (en) | Anti-allergy purslane repairing mask and preparation method thereof | |
| CN107496286B (en) | Water-replenishing and moistening type water emulsion capable of fading fine wrinkles and preparation method thereof | |
| CN111973544A (en) | Carnosine firming lifting mask and preparation method thereof | |
| CN111973496A (en) | Seaweed moisturizing mask and preparation method thereof | |
| CN114831915A (en) | Moisturizing and repairing eye cream and preparation method thereof | |
| CN113368026A (en) | Moisturizing, anti-wrinkle, nourishing and skin-care gel and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20201124 |
|
| WW01 | Invention patent application withdrawn after publication |